Jack Khattar
Gründer bei SUPERNUS PHARMACEUTICALS, INC.
Vermögen: 57 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Jack Khattar
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 27 | |
| Public Company | Pharmaceuticals: Major | 19 | |
| Public Company | Biotechnology | 16 | |
| Subsidiary | Pharmaceuticals: Major | 15 | |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania.
10
| Private Company | Investment Managers | 10 |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Shire Laboratories, Inc.
 Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD.
4
| Extinct | Miscellaneous Commercial Services | 4 |
CIMA Labs, Inc.
 CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN.
3
| Subsidiary | Pharmaceuticals: Other | 3 |
Rockville Economic Development, Inc.
 Rockville Economic Development, Inc. Miscellaneous Commercial ServicesCommercial Services Rockville Economic Development, Inc. is a public-private partnership that aims to strengthen and broaden the economy of Rockville, MD through entrepreneurship, attraction, expansion, retention, and incentive programs. The non-profit company provides useful research and statistics about demographics, workforce, and business in Rockville to help businesses succeed. Rockville is an ideal place for business success, particularly in key industries such as biohealth and tech. The company also creates partnerships throughout the community to expand a network of services and offer critical resources for small businesses.
2
| Non-Profit Organization | Miscellaneous Commercial Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jack Khattar
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | General Counsel General Counsel Sales & Marketing Sales & Marketing | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| VANDA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO Sales & Marketing | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
| University of Virginia | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
CyDex Pharmaceuticals, Inc.
 CyDex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CyDex Pharmaceuticals, Inc. provides pharmaceutical discovery, development and manufacturing services. Its product Captisol is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE). The firm engages in technology with substantial characterization, safety documentation and regulatory review. The company was founded in 1990 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| New York University | College/University | Masters Business Admin Masters Business Admin | |
Corsair Pharma, Inc.
 Corsair Pharma, Inc. BiotechnologyHealth Technology Corsair Pharma, Inc. is a development stage biotechnology company. It focuses on the development of novel prodrugs of treprostinil to treat patients with pulmonary arterial hypertension using a once-daily transdermal patch. The company is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Neuraptive Therapeutics, Inc.
 Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Biotechnology | Chairman Director/Board Member | |
| University of Missouri | College/University | Doctorate Degree Undergraduate Degree | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| George Washington University | College/University | Undergraduate Degree Undergraduate Degree | |
| AVEDRO, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| Wesleyan University | College/University | Undergraduate Degree Masters Business Admin | |
| University of Maryland | College/University | Undergraduate Degree Doctorate Degree | |
| University of Oxford | College/University | Undergraduate Degree Graduate Degree | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| GELESIS INC | Biotechnology | Director/Board Member Chairman | |
Broadview Ventures, Inc.
 Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures, Inc. (Broadview Ventures) is a venture capital firm founded in 2008. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Analyst | |
Flamingo Therapeutics BV
 Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Biotechnology | Chairman Director/Board Member | |
| The University of Chicago | College/University | Masters Business Admin Doctorate Degree | |
Tiburio Therapeutics, Inc.
 Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Tiburio Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It provides novel treatments for rare neuroendocrine tumors and endocrine diseases. The company was founded by James Gregg McArthur in January 2019 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chief Executive Officer | |
iNetworks Advisors, Inc
 iNetworks Advisors, Inc Investment ManagersFinance iNetworks Advisors Inc (iNetworks) is a private equity firm founded in 1999 by Anthony M. Lancenere and Charlie A. Schliebs. The firm is headquartered in Pittsburgh, Pennsylvania. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Masters Business Admin Doctorate Degree | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigte Staaten | 46 |
| Schweiz | 3 |
| Vereinigtes Königreich | 2 |
| Frankreich | 2 |
| Belgien | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 20 |
| Finance | 4 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 508 |
| Corporate Officer/Principal | 211 |
| Independent Dir/Board Member | 144 |
| Chairman | 98 |
| Undergraduate Degree | 85 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Michael Barrett | 49 |
| Jonathan Silverstein | 42 |
| Georges Gemayel | 33 |
| Kush Parmar | 32 |
| Leonard Schaeffer | 32 |
| Mette Agger | 30 |
| Alan Crane | 29 |
| Charles Newhall | 29 |
| Ellen Richstone | 28 |
| Michael Bigham | 27 |
| Bill Ericson | 26 |
| Ivan Philip Gergel | 24 |
| Rajeev Dadoo | 24 |
| Douglas Giordano | 22 |
| David Mahoney | 21 |
- Börse
- Insiders
- Jack Khattar
- Unternehmensverbindungen
